Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Reversal of .beta./A4 amyloid peptide induced morphological changes in neuronal cells by antisense oligonucleotides

Reversal of .beta./A4 amyloid peptide induced morphological changes in neuronal cells by antisense oligonucleotides

US Patent 5670634 · Granted Sep 23, 1997

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic compositions for treating pain via multiple targets2024
Immune modulation with TLR9 agonists for cancer treatment2022
Immune modulation with TLR9 agonists for cancer treatment2020
Immune modulation with TLR9 agonists for cancer treatment2020
Immune modulation with TLR9 agonists for cancer treatment2019
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor2018
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor2018
Compositions for inhibiting checkpoint gene expression and uses thereof2017
Toll-like receptor 9 antagonist and methods of use thereof2017
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor2017
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor2016
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor2016